Periscope Capital’s Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one CHAQ.U Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-254,400
Closed -$2.69M 728
2020
Q4
$2.69M Hold
254,400
0.14% 225
2020
Q3
$2.67M Sell
254,400
-245,900
-49% -$2.56M 0.19% 170
2020
Q2
$5.25M Buy
+500,300
New +$5.02M 0.47% 78

Other funds holding CHAQ.U

Periscope Capital's CHAQ.U Position: Q1 2021 in Review

Periscope Capital sold out of Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one (CHAQ.U) in Q1 2021, closing a stake of 254,400 shares — an estimated $2.69M sold.

Periscope Capital first reported a position in CHAQ.U in Q2 2020 and held it in 3 quarters. The position peaked at $5.25M in Q2 2020. 7 funds tracked by Wall St. Rank hold CHAQ.U as of Q1 2021.

  • Periscope Capital reported no remaining Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position as of Q1 2021 after selling out during the quarter.
  • Periscope Capital sold 254,400 Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one shares in Q1 2021, an estimated $2.69M.
  • Periscope Capital first reported a position in Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one in Q2 2020 and held it in 3 quarters.
  • Periscope Capital's Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one position peaked at $5.25M in Q2 2020.
  • 7 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Units, each consisting of one share of Common Stock, and one as of Q1 2021.

Based on Periscope Capital's 13F filing for Q1 2021, filed 14 May 2021.